全文获取类型
收费全文 | 5642篇 |
免费 | 297篇 |
国内免费 | 12篇 |
专业分类
儿科学 | 108篇 |
妇产科学 | 39篇 |
基础医学 | 447篇 |
口腔科学 | 1篇 |
临床医学 | 500篇 |
内科学 | 3081篇 |
皮肤病学 | 36篇 |
神经病学 | 611篇 |
特种医学 | 57篇 |
外科学 | 409篇 |
综合类 | 218篇 |
预防医学 | 156篇 |
眼科学 | 28篇 |
药学 | 122篇 |
肿瘤学 | 138篇 |
出版年
2024年 | 3篇 |
2023年 | 69篇 |
2022年 | 37篇 |
2021年 | 83篇 |
2020年 | 40篇 |
2019年 | 13篇 |
2018年 | 92篇 |
2017年 | 85篇 |
2016年 | 107篇 |
2015年 | 115篇 |
2014年 | 108篇 |
2013年 | 133篇 |
2012年 | 574篇 |
2011年 | 601篇 |
2010年 | 214篇 |
2009年 | 168篇 |
2008年 | 580篇 |
2007年 | 527篇 |
2006年 | 527篇 |
2005年 | 517篇 |
2004年 | 403篇 |
2003年 | 386篇 |
2002年 | 287篇 |
2001年 | 166篇 |
2000年 | 26篇 |
1999年 | 13篇 |
1998年 | 32篇 |
1997年 | 10篇 |
1996年 | 13篇 |
1995年 | 4篇 |
1994年 | 3篇 |
1993年 | 3篇 |
1991年 | 3篇 |
1990年 | 2篇 |
1986年 | 2篇 |
1985年 | 2篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1965年 | 1篇 |
排序方式: 共有5951条查询结果,搜索用时 15 毫秒
41.
42.
43.
Melloni C Alexander KP Milford-Beland S Newby LK Szczech LA Pollack CV Kirk JD Christenson RH Harrington RA Gibler WB Ohman EM Peterson ED Roe MT;Crusade Investigators 《Clinical cardiology》2008,31(3):125-129
BACKGROUND: The prognostic value of cardiac troponins (cTn) in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS) and chronic kidney disease (CKD) is debated. HYPOTHESIS: We tested the performance of cTnI and cTnT for risk stratification in patients with CKD and evaluated the prognostic significance of cTnI and cTnT elevations by their magnitude across the range of CKD severity. METHODS: We examined correlations among cTn elevation, CKD, and in-hospital mortality in 31,586 high-risk patients with NSTE ACS included in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines initiative (CRUSADE). Cardiac tropinins I and T levels were categorized as ratios of each site's upper limit of normal (ULN) for myocardial necrosis: normal (cTn ratio < or =1 x ULN), mild (cTn ratio > 1-3 x ULN), and major (cTn ratio > 3 x ULN) elevation. Estimated glomerular filtration rate (eGFR) was calculated using the abbreviated Modification of Diet in Renal Disease equation. Stages of CKD were categorized as normal to mild (eGFR > 60 mL/min), moderate (eGFR 30-60 mL/min), or severe (eGFR < 30 mL/min). RESULTS: Mortality increased more steeply across CKD stages (2.0%-12.9%) than across cTn ratio categories (2.7%-5.4%). In normal or mild CKD, mortality was low regardless of cTn elevations. In moderate CKD, mortality increased incrementally with cTnI (3.3% versus 5.4% versus 7.4%) and cTnT (3.7% versus 5.3% versus 7.3%) elevation. Among severe CKD patients, only major cTn elevations further distinguished risk (cTnI: 10.1% versus 9.7% versus 14.6%; cTnT: 7.0% versus 5.7% versus 14.0%). CONCLUSIONS: In patients with CKD, cTnI and cTnT perform equally in differentiating short-term prognosis following NSTE ACS; however, the prognostic impact of cTn is dependent upon the degree of CKD severity. 相似文献
44.
Yosefy C Ginsberg GM Dicker D Viskoper JR Tulchinsky TH Leibovitz E Gavish D;IBPC Investigators 《Blood pressure》2003,12(4):225-231
Aims: Blood pressure (BP) reduction is crucial in reducing cardiovascular morbidity and mortality. The IBPC (Israeli Blood Pressure Control) program was initiated in order to enhance the control of modifiable risk factors among high-risk hypertensive patients under follow-up by general practitioners in Israel. The cost effectiveness of an intervention program is an important factor in the decision-making process of its implementation and therefore was evaluated here. The objective of this evaluation is to estimate the costs, monetary savings and benefits in terms of QALYs (quality-adjusted life years) that would be expected if the program were to be expanded to 100 clinics nationwide, enabling around 14 800 persons to be treated. Methods: Hypertensive patients were screened in 30 general practice clinics, supervised by specialists in family medicine, each seeing 1000-5000 patients; 50-250 hypertensive patients were diagnosed at each participating clinic. BP levels, body mass index (BMI), lipid and glucose levels, as well as target organ damage and medications were recorded for all patients. Results: A total of 4948 (2079, 42% males) were registered. Mean age was 64.8 ± 12 years. After 1 year of follow-up versus baseline, the various parameters were as follows: BP control was achieved in 46.4% vs 29% of all hypertensive patients. LDL control (JNC VI criteria) was achieved in 41.7% vs 31.2% of all patients. Fasting plasma glucose control (glucose 200 mg/dl. Obesity (BMI >30 kg/m[Formula: See Text]) was noted in 36.7% vs 43.8% at baseline. The cost utility analysis of the reduction in risk factors was calculated based on the international dicta applied to the reduction in risk factors as a result of treatment. For 100 clinics nationwide and 14 800 persons to be treated the net saving to health services would be $977 993 and the increase in QALYs would be 602 years. Conclusions: Better risk factor control in hypertensive patients by general practitioners could reduce morbidity and mortality as well as be cost effective. 相似文献
45.
American College of Rheumatology Provisional Criteria for Global Flares in Childhood‐Onset Systemic Lupus Erythematosus 下载免费PDF全文
Hermine I. Brunner Michael Holland Michael W. Beresford Stacy P. Ardoin Simone Appenzeller Clovis A. Silva Francisco Flores Beatrice Goilav Scott E. Wenderfer Deborah M. Levy Angelo Ravelli Raju Khunchandani Tadej Avcin Marisa S. Klein‐Gitelman Brian M. Feldman Nicolino Ruperto Jun Ying the PRCSG PRINTO Investigators 《Arthritis care & research》2018,70(6):813-822
46.
47.
48.
Sean H. Rhyee Lynn Farrugia Sharan L. Campleman Paul M. Wax Jeffrey Brent On behalf of the Toxicology Investigators Consortium 《Journal of medical toxicology》2015,11(4):388-409
The Toxicology Investigators Consortium (ToxIC) Case Registry was established in 2010 by the American College of Medical Toxicology. The Registry includes all medical toxicology consultations performed at participating sites. The Registry was queried for all cases entered between January 1 and December 31, 2014. Specific data reviewed for analysis included demographics (age, gender, ethnicity), source of consultation, reasons for consultation, agents involved in toxicological exposures, signs, symptoms, clinical findings, fatalities, and treatment. In 2014, 9172 cases were entered in the Registry across 47 active member sites. Females accounted for 51.1 % of cases. The majority (65.1 %) of cases were adults between the ages of 19 and 65. Caucasians made up the largest identified ethnic group (48.9 %). Most Registry cases originated from the inpatient setting (93.5 %), with a large majority of these consultations coming from the emergency department or inpatient admission services. Intentional and unintentional pharmaceutical exposures continued to be the most frequent reasons for consultation, accounting for 61.7 % of cases. Among cases of intentional pharmaceutical exposure, 62.4 % were associated with a self-harm attempt. Non-pharmaceutical exposures accounted for 14.1 % of Registry cases. Similar to the past years, non-opioid analgesics, sedative-hypnotics, and opioids were the most commonly encountered agents. Clinical signs or symptoms were noted in 81.9 % of cases. There were 89 recorded fatalities (0.97 %). Medical treatment (e.g., antidotes, antivenom, chelators, supportive care) was rendered in 62.3 % of cases. Patient demographics and exposure characteristics in 2014 Registry cases remain similar to prior years. The majority of consultations arose in the acute care setting (emergency department or inpatient) and involved exposures to pharmaceutical products. Among exposures, non-opioid analgesics, sedative/hypnotics, and opioids were the most frequently encountered. A majority of cases required some form of treatment, but fatalities were rare.
Electronic supplementary material
The online version of this article (doi:10.1007/s13181-015-0507-7) contains supplementary material, which is available to authorized users. 相似文献49.